AstraZeneca, private investors bet on ADC Therapeutics with $200 million private financing

2017-10-25 07:10:51

The proceeds from the investment will be used to progress ADC’s therapeutics into planned registrational trialsBy Team ABLEADC Therapeutics (ADCT), a Switzerland-based oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, has raised $200 million through a private placement. It is known that the

Read more

Fullife Healthcare expands global footprint in preventive healthcare

2017-10-25 07:10:07

Fullife aims to achieve 5-fold revenue growth from international markets by 2022 with its OTC portfolio By Team ABLEMumbai-based Fullife Healthcare Private Limited has announced in a press release that the company is working towards growing its international division through its \'Effervescent Technology\', with the acquisition of Switzerland-based, Novelty Pharma. Fullife says that the company is

Read more

DBT invites applications for Boston Bangalore Biosciences Beginnings Program

2017-10-25 07:08:30

The aim of the workshop is to introduce Indian students to the emerging area of genomics and enable them to explore Next Generation Sequencing technologiesBy Team ABLESponsored by the Department of Biotechnology, Government of India, the aim of this intensive workshop is to introduce highly talented Indian students to the emerging area of genomics and enable them to explore the power and excitemen

Read more

Buenos Aires\' PureCircle Stevia Institute achieves breakthrough in Stevia plant genome sequencing

2017-10-25 07:03:16

Lead scientists from PureCircle Stevia Institute and KeyGene have unveiled a research showing the annotated, genome sequences of three stevia cultivarsBy Team ABLEClaimed to be as a discovery for the first time, scientists in Buenos Aires have completed the sequencing of the stevia plant genome. Lead scientists from PureCircle Stevia Institute and KeyGene have unveiled this breakthrough in researc

Read more

University of Bristol researchers’ discovery offer new hope of reversing antibiotic resistance

2017-10-25 07:02:03

The findings suggest that if chemicals could be developed to inhibit ?-lactamase enzymes, a significant proportion of antibiotic resistance could successfully be reversedBy Team ABLEResistance to antibiotics is becoming increasingly prevalent and threatens to undermine healthcare systems across the globe. Antibiotics including penicillins, cephalosporins and carbapenems are known as ?-lactams and

Read more

Hyderabad Central University to set up Biotech Incubator

2017-10-20 13:41:28

One of India’s top academic centers, University of Hyderabad (UOH) will support entrepreneurship in a big way by setting up an exclusive Biotech Incubator on its sprawling campus in Hyderabad to host biotech start-upsBy Narayanan SureshHyderabad, 20 October 2017:  The School of Life Sciences (SLS) of University of Hyderabad, is all set to open a 20,000 sq ft Biotech Incubator within its bui

Read more

Merck gets USFDA, EMA approval for gene therapy product

2017-10-20 11:25:14

Merck’s Carlsbad, US, manufacturing facility passes FDA and EMA inspectionsBy Team ABLELeading science and technology company Merck has announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance viral and gene therapy products has completed both a U.S. Food & Drug Administration (FDA) Pre-License inspection and a European Medicines Agency (EMA) Mar

Read more

US NIFA extends support to bridge gaps in biotechnology innovations and policies

2017-10-20 11:21:55

The U.S. Department of Agriculture\'s (USDA) National Institute of Food and Agriculture (NIFA) has announced its support for projects to help bridge the gap between biotechnology innovations and the policies on how to use them. These grants are funded through NIFA\'s Biotechnology Risk Assessment Research Grants (BRAG) Program.By Team ABLE\"Biotechnology offers innovative tools to address the prob

Read more

Roivant Sciences Enters into Development Partnership with AstraZeneca

2017-10-20 11:17:21

Roivant Sciences has entered into a development partnership with AstraZeneca for a deprioritized investigational drugBy Team ABLESoftBank-funded and 32-year-old, Vivek Ramaswamy led Roivant Sciences has entered into a development partnership with AstraZeneca for a deprioritized investigational drug in an undisclosed indication. The drug will be developed by Roivant in a new therapeutic area that i

Read more

Visterra signs research collaboration with Vir Biotechnology

2017-10-20 11:12:27

The collaboration combines Visterra’s proprietary Hierotope Platform Technology and Vir Biotechnology’s expertise in research & development for infectious diseasesBy Team ABLECambridge-located Visterra Inc has entered into a research collaboration, exclusive license, and option agreement with Vir Biotechnology Inc. to develop and commercialize select programs for infectious diseases derive

Read more